EGIS 11150 is a adrenergic reporter antagonist that has high affinity for adrenergic α1, α2c, 5-HT2A reporters. EGIS 11150 is an antipsychotic compound with procognitive efficacy[1].
References
[1] Gacsályi I, et al. Egis-11150: a candidate antipsychotic compound with procognitive efficacy in rodents. Neuropharmacology. 2013 Jan;64:254-63. DOI:10.1016/j.neuropharm.2012.07.017
